Meningococcal B Recombinant Vaccine
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for Meningococcal B Recombinant Vaccine, covering 2015-03-06 to 2018-06-15. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Meningococcal B Recombinant Vaccine When Administered Concomitantly With Routine Vaccines to Healthy Infants of 2 Months of Age and Older, in Taiwan. [Phase 3]